ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her state of practice after we conducted our analysis. The updated address appears on this page.

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,749Medicare Part D Prescriptions Filled, Including Refills
$367K Total Retail Price of All Prescriptions
466 Patients Receiving at Least One Drug in Part D
21%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 990 179 S3
TRAMADOL HCL 276 50
ENDOCET 270 43 S2
LISINOPRIL 265 67
ZOLPIDEM TARTRATE 260 60
OMEPRAZOLE 219 54
MELOXICAM 209 49
SIMVASTATIN 204 52
AMLODIPINE BESYLATE 199 25
OXYCODONE HCL-ACETAMINOPHEN 183 50 S2
METHADONE HCL 158 16 S2
METFORMIN HCL 153 43
GABAPENTIN 151 18
OXYCONTIN 127 0 S2
TIZANIDINE HCL 122 13
LEVOTHYROXINE SODIUM 108 0
AZITHROMYCIN 101 23
LYRICA 100 15
NEXIUM 89 23
CYCLOBENZAPRINE HCL 88 0 R
POTASSIUM CHLORIDE 83 19
HYDROCHLOROTHIAZIDE 80 23
FUROSEMIDE 78 31
CARVEDILOL 71 0
LOSARTAN-HYDROCHLOROTHIAZIDE 65 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 0
SPIRIVA 58 0
HYDRALAZINE HCL 58 24
VENTOLIN HFA 58 0
PROAIR HFA 58 20
PROMETHAZINE HCL 54 0 R
PRAVASTATIN SODIUM 54 0
LOSARTAN POTASSIUM 53 0
ADVAIR DISKUS 53 0
SINGULAIR 52 13
MONTELUKAST SODIUM 51 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.